Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $13.08B.
ENTERPRISE VALUE (EV)
$13.08B
Corcept Therapeutics Incorporated
Market Cap
$13.19B
Enterprise Value (EV)
$13.08B
Market Cap
$12.17B
Enterprise Value (EV)
$14.01B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Corcept Therapeutics Incorporated (CORT) | $13.19B | $13.08B |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | $14.77B |
| ICON Public Limited Company (ICLR)vs › | $12.89B | $15.45B |
| Baxter International Inc. (BAX)vs › | $12.52B | $20.04B |
| Penumbra, Inc. (PEN)vs › | $12.49B | $12.50B |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | $13.75B |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | $14.01B |
| Encompass Health Corporation (EHC)vs › | $12.00B | $14.73B |
| Tempus AI, Inc. (TEM)vs › | $14.64B | $15.48B |
| Exelixis, Inc. (EXEL)vs › | $14.79B | $14.68B |
Market Cap
$13.19B
Total Debt
$5.02M
Cash
$120.50M
Enterprise Value
$13.08B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
